RankAlpha logo
Back to Rankings

FRMM

Forum MarketsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart

AI scenario view

RankAlpha Sentiment Codex
B+
Bull case
20%
Probability
Target price
$5.20
Analysis reference price unavailable
Analysis 2026-05-20 · RankAlpha Sentiment Codex
Most likely
B
Base case
50%
Probability
Target price
$3.40
Analysis reference price unavailable
Analysis 2026-05-20 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$1.90
Analysis reference price unavailable
Analysis 2026-05-20 · RankAlpha Sentiment Codex

The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented

AI sentiment snapshot

Latest data as of 2026-05-20
Recent news sentiment (30D)
0.0
Mixed
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Weekly research (10D)
-
Unavailable
Sentiment proxy
+29.4
Score

AI commentary

Primary-source coverage is strong for the quarter and the strategic pivot, but forward visibility is limited, no analyst target revisions are available in the packet, and the available peer candidates are not direct operating comps. This remains a low-conviction monitoring setup rather than a confirmed re-rating.

RankAlpha Sentiment Codex - 2026-05-20
Open full AI memo

Evidence flagged

peer set is too generic or lacks enough direct operating comparators; small-cap biotech peer set is too weak or includes unrelated comparators for a standard-conviction report

Impact
tentative
Confidence
-

AI events

2026-05-14eventQ1 2026 print and webcast landed on May 14High impact

Forum Markets filed an 8-K on 2026-05-14 and a 10-Q on 2026-05-15 for the quarter ended 2026-03-31. The quarter showed cash and cash equivalents of $65.9m versus $8.0m at 2025-12-31, total assets of $207.6m, liabilities of $39.3m, and net loss from continuing operations of $77.5m, with the loss profile still heavily influenced by non-operating fair-value and digital-asset items. [#8-K-2026-05-14] [#10-Q-2026-05-15]

2026-12-31catalystStrategic pivot toward RWA tokenization and ETH-yield assetsHigh impact

The 2025 10-K says management shifted in the third calendar quarter of 2025 to prioritize acquiring, structuring, and tokenizing real-world assets, deploying ETH in DeFi to generate yield, and owning cash-flowing assets that can support the new strategy. That creates multi-quarter upside if execution works, but the filing also flags custody, regulatory, accounting, and digital-asset risks. [#10-K-2026-04-01]

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo
As of 2026-05-20 • Updated nightlySource: Internal modelMethodology